SECTORAL ASSET MANAGEMENT INC - Q3 2022 holdings

$508 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 109 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 20.5% .

 Value Shares↓ Weighting
UNH SellUNITEDHEALTH GRP INC$16,729,000
-9.3%
33,125
-7.8%
3.30%
-11.4%
HQY SellHEALTHEQUITY INC$15,657,000
+6.0%
233,100
-3.1%
3.08%
+3.7%
BMRN BuyBIOMARIN PHARMAC INC$13,837,000
+17.8%
163,230
+15.2%
2.73%
+15.2%
EVH  EVOLENT HEALTH INCcl a$13,371,000
+17.0%
372,1420.0%2.63%
+14.4%
NARI SellINARI MED INC$13,242,000
+6.0%
182,293
-0.8%
2.61%
+3.7%
IRTC BuyIRHYTHM TECHNOLOGIES$12,893,000
+59.1%
102,911
+37.2%
2.54%
+55.5%
BuyR1 RCM INC$12,648,000
-0.1%
682,594
+13.0%
2.49%
-2.3%
PTCT SellPTC THERAPEUTICS I$11,992,000
+24.8%
238,891
-0.4%
2.36%
+22.0%
ARVN SellARVINAS INC$11,103,000
-1.2%
249,567
-6.5%
2.19%
-3.4%
JNJ  JOHNSON & JOHNSON$11,084,000
-8.0%
67,8500.0%2.18%
-10.0%
INSM SellINSMED INC$11,074,000
+8.9%
514,092
-0.3%
2.18%
+6.5%
ICLR BuyICON PLC$9,910,000
+27.2%
53,925
+50.0%
1.95%
+24.4%
PRVA SellPRIVIA HEALTH GROUP$9,305,000
+7.5%
273,200
-8.1%
1.83%
+5.1%
ATRC SellATRICURE INC$8,857,000
-5.2%
226,532
-0.9%
1.74%
-7.3%
EXEL BuyEXELIXIS INC$8,677,000
+8.8%
553,375
+44.5%
1.71%
+6.3%
SYNH BuySYNEOS HEALTH INCcl a$8,622,000
-21.2%
182,856
+19.7%
1.70%
-23.0%
APLS SellAPELLIS PHARMACEUTIC$8,469,000
+22.2%
123,990
-19.1%
1.67%
+19.5%
SWAV SellSHOCKWAVE MEDICAL$8,231,000
+38.9%
29,600
-4.5%
1.62%
+35.8%
LNTH BuyLANTHEUS HLDGS INC$8,136,000
+38.9%
115,687
+30.4%
1.60%
+35.8%
AXNX SellAXONICS INC$8,051,000
+19.7%
114,296
-3.7%
1.59%
+17.0%
AGLY BuyAGILITI INC$7,981,000
-12.2%
557,747
+25.8%
1.57%
-14.2%
DNLI BuyDENALI THERAPEUTICS$7,468,000
+25.6%
243,350
+20.4%
1.47%
+22.8%
INSP SellINSPIRE MED SYS INC$7,414,000
-21.4%
41,800
-19.1%
1.46%
-23.1%
BPMC BuyBLUEPRINT MEDICINES$7,241,000
+75.0%
109,900
+34.2%
1.43%
+71.1%
ABBV BuyABBVIE INC$7,120,000
+15.4%
53,050
+31.6%
1.40%
+12.8%
BLU BuyBELLUS HEALTH INC$6,488,000
+40.0%
614,429
+22.5%
1.28%
+36.8%
NewCINCOR PHARMA INC$6,417,000195,534
+100.0%
1.26%
TVTX BuyTRAVERE THERAPEUTICS$6,153,000
+9.5%
249,700
+7.6%
1.21%
+7.0%
RXDX SellPROMETHEUS BIOSCIENC$6,090,000
+25.1%
103,210
-40.2%
1.20%
+22.3%
FOLD BuyAMICUS THERAPEUTICS$5,979,000
-0.7%
572,682
+2.1%
1.18%
-3.0%
LLY  LILLY ELI & CO$5,954,000
-0.3%
18,4150.0%1.17%
-2.5%
RCUS SellARCUS BIOSCIENCES$5,939,000
-24.8%
227,032
-27.2%
1.17%
-26.5%
HZNP BuyHORIZON THERAPEUTICS$5,846,000
+47.1%
94,450
+89.6%
1.15%
+43.8%
NewAMYLYX PHARMACEUTIC$5,782,000205,400
+100.0%
1.14%
ITCI BuyINTRA CELLULAR THERA$5,698,000
+9.9%
122,450
+34.9%
1.12%
+7.6%
PFE  PFIZER INC$5,663,000
-16.5%
129,4000.0%1.12%
-18.4%
CTIC NewCTI BIOPHARMA CORP$5,636,000968,300
+100.0%
1.11%
SBTX NewSILVERBACK THERAPEUT$5,519,0001,045,234
+100.0%
1.09%
HALO BuyHALOZYME THERAPEUTIC$5,433,000
-5.3%
137,400
+5.4%
1.07%
-7.4%
HUM SellHUMANA INC$5,398,000
-18.9%
11,125
-21.8%
1.06%
-20.8%
TMCI SellTREACE MED CONCEPT$5,378,000
-0.4%
243,674
-35.3%
1.06%
-2.6%
THC  TENET HEALTHCARE$5,235,000
-1.9%
101,5000.0%1.03%
-4.1%
ALKS BuyALKERMES PLC$5,189,000
-8.2%
232,400
+22.5%
1.02%
-10.2%
SILK SellSILK ROAD MEDICAL$5,130,000
-37.8%
114,000
-49.7%
1.01%
-39.2%
ABT SellABBOTT LABS$5,007,000
-18.8%
51,748
-8.8%
0.99%
-20.6%
MRK  MERCK & CO INC$4,973,000
-5.5%
57,7500.0%0.98%
-7.6%
BSX  BOSTON SCIENTIFIC$4,918,000
+3.9%
126,9760.0%0.97%
+1.7%
BMY BuyBRISTOL MYERS SQUIBB$4,656,000
+65.6%
65,500
+79.5%
0.92%
+62.0%
ALNY BuyALNYLAM PHARMACUETCL$4,540,000
+158.7%
22,680
+88.5%
0.89%
+152.5%
STAA  STAAR SURGICAL CO$4,409,000
-0.5%
62,5000.0%0.87%
-2.7%
SGFY NewSIGNIFY HEALTH INC$4,373,000150,000
+100.0%
0.86%
KRTX SellKARUNA THERAPEUTICS$4,343,000
+42.9%
19,310
-19.6%
0.86%
+39.9%
RCKT  ROCKET PHARMACEUTICA$4,322,000
+16.0%
270,7900.0%0.85%
+13.3%
ARQT BuyARCUTIS BIOTHERAPE$4,223,000
+10.1%
220,985
+22.8%
0.83%
+7.6%
MRTX SellMIRATI THERAPEUTICS$4,157,000
-9.7%
59,516
-13.3%
0.82%
-11.7%
FATE  FATE THERAPEUTICS$4,101,000
-9.6%
183,0000.0%0.81%
-11.6%
IMGN SellIMMUNOGEN INC$4,057,000
-4.1%
848,744
-9.7%
0.80%
-6.3%
CYTK SellCYTOKINETICS INC$4,043,000
+22.5%
83,450
-0.7%
0.80%
+19.8%
NTLA  INTELLIA THERAPEUT$3,994,000
+8.1%
71,3800.0%0.79%
+5.6%
IQV BuyIQVIA HOLDINGS INC$3,677,000
+5.9%
20,300
+26.9%
0.72%
+3.4%
AMGN SellAMGEN INC$3,656,000
-7.7%
16,220
-0.4%
0.72%
-9.9%
CNC SellCENTENE CORP DEL$3,548,000
-12.7%
45,600
-5.1%
0.70%
-14.7%
BIIB SellBIOGEN INC$3,538,000
+28.5%
13,252
-1.9%
0.70%
+25.6%
ALT BuyALTIMMUNE INC$3,436,000
+95.8%
269,100
+79.4%
0.68%
+91.2%
SGEN SellSEAGEN INC$3,376,000
-41.3%
24,670
-24.2%
0.66%
-42.7%
SellRALLYBIO CORP$3,377,000
+29.5%
233,381
-32.4%
0.66%
+26.7%
ARWR SellARROWHEAD PHARMACEUT$3,265,000
-20.6%
98,800
-15.4%
0.64%
-22.4%
BEAM NewBEAM THERAPEUTICS$3,130,00065,700
+100.0%
0.62%
TMO  THERMO FISHER SCI$2,962,000
-6.6%
5,8400.0%0.58%
-8.6%
MDT BuyMEDTRONIC PLC$2,548,000
+11.1%
31,551
+23.5%
0.50%
+8.7%
OLMA NewOLEMA PHARMACEUTICAL$2,437,000883,056
+100.0%
0.48%
CERT  CERTARA INC$2,299,000
-38.1%
173,1290.0%0.45%
-39.5%
VRTX SellVERTEX PHARMACEUTICL$2,293,000
+0.2%
7,918
-2.5%
0.45%
-2.0%
REGN BuyREGENERON PHARMCTCLS$2,287,000
+20.5%
3,320
+3.4%
0.45%
+18.1%
GILD  GILEAD SCIENCES INC$2,246,000
-0.2%
36,4000.0%0.44%
-2.4%
DHR  DANAHER CORP$2,228,000
+1.9%
8,6250.0%0.44%
-0.5%
MRNA BuyMODERNA INC$2,163,000
-16.3%
18,293
+1.1%
0.43%
-18.2%
CI  CIGNA CORP$2,164,000
+5.3%
7,8000.0%0.43%
+2.9%
SYK NewSTRYKER CORP$2,106,00010,400
+100.0%
0.42%
MOH SellMOLINA HEALTHCARE$2,070,000
-27.9%
6,275
-38.9%
0.41%
-29.5%
ANTM SellELEVANCE HEALTH INC$1,931,000
-27.2%
4,250
-22.7%
0.38%
-29.0%
 EFFECTOR THERAPEUTCS$1,363,000
-59.7%
2,382,6440.0%0.27%
-60.6%
ZNTL NewZENTALIS PHARMACEU$1,300,00060,000
+100.0%
0.26%
AZN BuyASTRAZENECAspn adr$1,070,000
-1.3%
19,510
+18.9%
0.21%
-3.2%
ILMN BuyILLUMINA INC$881,000
+39.6%
4,620
+35.1%
0.17%
+37.0%
OM NewOUTSET MED INC$797,00050,000
+100.0%
0.16%
BGNE BuyBEIGENE LIMITEDspn adr$779,000
-5.2%
5,780
+13.8%
0.15%
-7.8%
RPRX SellROYALTY PHARMA PLC$488,000
-16.2%
12,140
-12.3%
0.10%
-17.9%
ZLAB  ZAI LAB LTDadr$479,000
-1.4%
14,0000.0%0.09%
-4.1%
RDY BuyDR REDDYS LABS LTDadr$471,0000.0%9,004
+5.9%
0.09%
-2.1%
INCY  INCYTE CORPORATION$472,000
-12.3%
7,0800.0%0.09%
-13.9%
ARGX  ARGENX SEspn adr$448,000
-6.9%
1,2700.0%0.09%
-9.3%
UTHR  UNITED THERAPEUTICS$401,000
-11.1%
1,9150.0%0.08%
-13.2%
LEGN SellLEGEND BIOTECH CORPspn adr$367,000
-33.3%
9,000
-10.0%
0.07%
-35.1%
BNTX BuyBIONTECH SEspn adr$364,000
+11.0%
2,700
+22.7%
0.07%
+9.1%
SNY SellSANOFIspn adr$338,000
-42.7%
8,900
-24.5%
0.07%
-43.7%
NBIX  NEUROCRINE BIOSCIENC$324,000
+9.1%
3,0500.0%0.06%
+6.7%
SellJASPER THERAPEUTICS$316,000
-77.1%
400,000
-44.1%
0.06%
-77.7%
SRPT  SAREPTA THERAPEUTICS$310,000
+47.6%
2,8000.0%0.06%
+45.2%
JAZZ  JAZZ PHARMA PLC$263,000
-14.3%
1,9700.0%0.05%
-16.1%
GH  GUARDANT HEALTH INC$257,000
+33.9%
4,7700.0%0.05%
+30.8%
IONS  IONIS PHARMACEUTICAL$197,000
+19.4%
4,4500.0%0.04%
+18.2%
ASND  ASCENDIS PHARMA A Sspn adr$195,000
+10.8%
1,8900.0%0.04%
+8.6%
FUSN BuyFUSION PHARMACEUTI$172,000
+81.1%
57,297
+50.0%
0.03%
+78.9%
MEDP  MEDPACE HOLDINGS$167,000
+5.0%
1,0600.0%0.03%
+3.1%
CRSP  CRISPR THERAPEUTICSnamen akt$163,000
+7.9%
2,4900.0%0.03%
+6.7%
A SellAGILENT TECHN INC$140,000
-5.4%
1,148
-8.0%
0.03%
-6.7%
NVCR BuyNOVOCURE LTD$122,000
+25.8%
1,600
+14.3%
0.02%
+20.0%
NVAX SellNOVAVAX INC$46,000
-98.2%
2,550
-94.8%
0.01%
-98.2%
VIR ExitVIR BIOTECHNOLOGY$0-4,200
-100.0%
-0.02%
RARE ExitULTRAGENYX PHARMAC$0-4,300
-100.0%
-0.05%
MREO ExitMEREO BIOPHARMA GRads$0-385,000
-100.0%
-0.09%
TALS ExitTALARIS THERAPEUTI$0-228,624
-100.0%
-0.21%
ExitEXSCIENTIA PLCads$0-201,388
-100.0%
-0.44%
MRVI ExitMARAVAI LIFESCIENCES$0-89,250
-100.0%
-0.51%
MASS Exit908 DEVICES INC$0-131,757
-100.0%
-0.55%
ITOS ExitITEOS THERAPEUTICS$0-147,900
-100.0%
-0.61%
AVTE ExitAEROVATE THERAPEUT$0-196,038
-100.0%
-0.62%
CNVY ExitCONVEY HEALTH SOL HL$0-400,000
-100.0%
-0.84%
TNDM ExitTANDEM DIABETES CARE$0-105,763
-100.0%
-1.26%
TPTX ExitTURNING POINT THERAP$0-90,000
-100.0%
-1.36%
BHVN ExitBIOHAVEN PHARMACTL$0-63,150
-100.0%
-1.85%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BIOMARIN PHARMAC INC42Q3 20236.7%
PTC THERAPEUTICS INC42Q3 20232.7%
DR REDDYS LABS LTD42Q3 20232.0%
GILEAD SCIENCES INC38Q3 20238.4%
INCYTE CORPORATION38Q3 20235.2%
VERTEX PHARMACEUTICL38Q3 20236.0%
AMICUS THERAPEUTICS INC37Q3 20236.6%
PFIZER INC35Q3 20236.3%
MERCK & CO. INC34Q3 20236.4%
MEDTRONIC PLC33Q3 20234.4%

View SECTORAL ASSET MANAGEMENT INC's complete holdings history.

Latest significant ownerships (13-D/G)

View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR2023-08-11
13F-HR2023-05-12
SC 13G/A2023-02-13
SC 13G2023-02-13
13F-HR2023-02-10
13F-HR2022-11-10

View SECTORAL ASSET MANAGEMENT INC's complete filings history.

Compare quarters

Export SECTORAL ASSET MANAGEMENT INC's holdings